NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

VKTX

Viking Therapeutics Inc

Apr 25 • 04:00PM ET

24.99

Dollar change -0.67
Percentage change -2.61	%

Healthcare • Biotechnology • USA • NASD

Peers: MDGL AKRO GLMD AKBA PRTG ARDX BOLD TVRD EYPT FGEN

| Held by: VTI VB XBI VXF VBK IWP SCHA IWF IWR VHT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.15	Insider Own	2.95%	Shs Outstand	112.29M	Perf Week	4.39%
Market Cap	2.81B	Forward P/E	-	EPS next Y	-2.44	Insider Trans	-11.52%	Shs Float	108.97M	Perf Month	-5.13%
Income	-128.24M	PEG	-	EPS next Q	-0.45	Inst Own	73.29%	Short Float	23.37%	Perf Quarter	-27.57%
Sales	0.00M	P/S	-	EPS this Y	-80.51%	Inst Trans	0.41%	Short Ratio	5.53	Perf Half Y	-59.71%
Book/sh	7.54	P/B	3.31	EPS next Y	-34.10%	ROA	-13.98%	Short Interest	25.46M	Perf Year	-61.51%
Cash/sh	7.58	P/C	3.29	EPS next 5Y	-	ROE	-14.40%	52W Range	18.92 - 81.86	Perf YTD	-37.90%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-23.00%	ROI	-15.13%	52W High	-69.47%	Beta	0.77
Dividend TTM	-	Quick Ratio	44.25	Sales past 5Y	0.00%	Gross Margin	-	52W Low	32.08%	ATR (14)	2.14
Dividend Ex-Date	-	Current Ratio	44.25	EPS Y/Y TTM	-23.84%	Oper. Margin	-	RSI (14)	49.25	Volatility	5.89% 9.02%
Employees	36	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.22	Target Price	89.50
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	-54.01%	Payout	-	Rel Volume	0.85	Prev Close	25.66
Sales Surprise	-	EPS Surprise	-25.00%	Sales Q/Q	-	Earnings	Apr 23 AMC	Avg Volume	4.61M	Price	24.99
SMA20	5.18%	SMA50	-7.16%	SMA200	-46.90%	Trades		Volume	3,959,460	Change	-2.61%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-08-25	Initiated	Goldman	Neutral	$30
Feb-13-25	Initiated	Scotiabank	Sector Outperform	$102
Feb-07-25	Initiated	Citigroup	Neutral	$38
Dec-02-24	Initiated	Piper Sandler	Overweight
Nov-22-24	Initiated	B. Riley Securities	Buy	$109
Nov-04-24	Reiterated	H.C. Wainwright	Buy	$90 → $102
Sep-11-24	Initiated	JP Morgan	Overweight	$80
Jun-27-24	Initiated	Morgan Stanley	Overweight	$105
May-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$115 → $116
Mar-26-24	Reiterated	Oppenheimer	Outperform	$116 → $138
Mar-07-24	Initiated	Jefferies	Buy	$110
Feb-28-24	Reiterated	Oppenheimer	Outperform	$46 → $116
May-31-23	Resumed	ROTH MKM	Buy	$32
Mar-28-23	Reiterated	Maxim Group	Buy	$15 → $25
Mar-17-23	Initiated	Stifel	Buy	$22
Jul-29-21	Resumed	BTIG Research	Buy	$20
May-25-21	Downgrade	Raymond James	Strong Buy → Outperform	$27 → $12
Jun-05-20	Initiated	BMO Capital Markets	Outperform	$14
May-05-20	Initiated	Chardan Capital Markets	Buy	$15
May-01-20	Initiated	BTIG Research	Buy	$9

Show Previous Ratings

Apr-26-25 08:50AM	Novo Nordisk: Examining Tariff And Pricing Risks (Seeking Alpha)
Apr-25-25 08:00AM	Viking Therapeutics Stock May Struggle After As-Expected Report (MarketBeat)
Apr-24-25 11:18AM	Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock? (Zacks)
09:16AM	Q1 2025 Viking Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
08:58AM	Viking Therapeutics: Q1 Earnings Overview - Hard To Understand Wall Street's Pessimism (Seeking Alpha)
06:31AM	Loading…
06:31AM	Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips (Zacks)
03:06AM	Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ... (GuruFocus.com)
Apr-23-25 08:48PM	Viking Therapeutics, Inc. (VKTX): Among Takeover Rumors Hedge Funds Are Buying (Insider Monkey)
07:46PM	Viking Therapeutics, Inc. (VKTX) Q1 2025 Earnings Call Transcript (Seeking Alpha)
04:05PM	Viking Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update (PR Newswire)
Apr-22-25 09:30AM	Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic? (Zacks) +7.42%
Apr-21-25 08:37AM	LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study (Zacks)
07:36AM	Viking Therapeutics to Report Q1 Earnings: What's in the Cards? (Zacks)
Apr-18-25 11:55AM	H.C. Wainwright still expects Viking to differentiate after Lilly data (TipRanks)
11:25AM	Eli Lilly jumps as results from weight-loss pill study rival competitors (TipRanks)
10:26AM	Loading…
10:26AM	JPMorgan says Lilly data highly favorable for Structure Therapeutics (TipRanks)
Apr-17-25 05:50PM	Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
04:10PM	Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill (Investor's Business Daily)
12:46PM	Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide (Motley Fool)
11:36AM	Wall Street Lunch: Obesity Pill Progress (Seeking Alpha)
10:28AM	89bio: Primary Asset Targeting 2 Potential Indications And Is In Late-Stage Development (Seeking Alpha)
10:00AM	2 Stocks Down by 25% or More This Year to Buy and Hold (Motley Fool)
09:30AM	Viking Therapeutics: A Lot More Compelling After The Meltdown - Initiating Cautious Buy (Rating Upgrade) (Seeking Alpha)
08:34AM	Eli Lilly Stock Rockets On Weight-Loss Pill Progress (Investor's Business Daily)
Apr-16-25 04:05PM	Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025 (PR Newswire)
10:33AM	Viking Therapeutics Stock Pops But Struggles to Hold Gains (MarketBeat)
07:05AM	Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip? (Zacks)
Apr-15-25 04:21PM	Viking Therapeutics: Trading The Volatility Of The Weight Loss Drug Market (Seeking Alpha) -5.94%
02:37PM	Viking Therapeutics' VK2735 Candidate Likely Boosted By Pfizer's Woes (Seeking Alpha)
12:57PM	Pfizer Halts Obesity Pill Development Amid Safety Concerns (Zacks)
10:35AM	Loading…
10:35AM	Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill (TipRanks)
10:15AM	Down 71%, Should You Buy the Dip on Viking Therapeutics Stock? (Motley Fool)
10:00AM	NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback (Zacks)
12:40AM	Why Viking Therapeutics, Inc. (VKTX) Skyrocketed On Monday? (Insider Monkey)
Apr-14-25 11:12AM	Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today (Motley Fool) +10.58%
Apr-12-25 02:45PM	3 Magnificent Stocks That Could Double or More by 2030 (Motley Fool)
Apr-10-25 05:07AM	Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years? (Motley Fool) -6.84%
Apr-08-25 10:09AM	LLY vs. NVO: Which Weight-Loss Drug Stock is a Stronger Play Now? (Zacks) -6.11%
Apr-07-25 09:14AM	NVO & LLY Shares Down on Exclusion of Obesity Drugs From Medicare (Zacks) -5.92%
Apr-03-25 11:50AM	Bumbershoot Holdings 2024 Investor Letter (Seeking Alpha) -5.69%
06:15AM	The Smartest Biotech Stocks to Buy With $50 (Motley Fool)
Apr-02-25 04:40AM	Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now? (Motley Fool) +7.40%
Apr-01-25 05:50PM	Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Mar-31-25 07:15AM	Which Healthcare Stock Is the Best Buy Right Now? (MarketBeat) -5.85%
Mar-27-25 09:30AM	Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet (Zacks)
08:31AM	VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug (Zacks)
Mar-26-25 04:27PM	Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study (Investor's Business Daily) -5.86%
07:05AM	Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity (PR Newswire)
Mar-24-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know (Zacks)
11:41AM	Motley Fool 2025 March Market Cap Showdown Championship (Motley Fool)
Mar-23-25 04:43AM	Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly (Motley Fool)
Mar-22-25 07:00AM	MarketBeat Week in Review - 03/17 - 03/21 (MarketBeat)
Mar-20-25 01:03PM	3 Promising Biotechs Trading Substantially Under Consensus Analyst Firm Price Targets (SeekingAlpha) -5.72%
07:19AM	1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street (Motley Fool)
Mar-19-25 09:53AM	Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy? (Fool)
Mar-18-25 08:45AM	Is Viking Therapeutics the Next Blockbuster GLP-1 Stock? (MarketBeat)
Mar-13-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note (Zacks)
Mar-12-25 09:55PM	Why Viking Therapeutics Inc. (VKTX) Is Skyrocketing Today? (Insider Monkey) +11.43%
12:08PM	Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped (Motley Fool)
11:35AM	B. Riley sees two key positives in Viking manufacturing agreement (TipRanks)
Mar-11-25 04:58PM	Viking strikes $150m deal to secure supply of obesity drug (Pharmaceutical Technology) -5.15%
04:06PM	Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled. (Investor's Business Daily)
01:25PM	Stellantis, Tesla, Viking Therapeutics: Market Minute (Yahoo Finance Video)
11:28AM	Viking Therapeutics closer to bringing its Ozempic competitor to market (Quartz)
09:51AM	H.C. Wainwright says Novo results support Viking obesity potential (TipRanks)
09:30AM	Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy? (Zacks)
08:25AM	Viking inks CordenPharma deal to boost obesity drug supply (BioPharma Dive)
07:03AM	Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735 (PR Newswire)
Mar-09-25 10:03AM	This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street (Motley Fool)
Mar-07-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
Mar-05-25 11:39AM	Why Viking Therapeutics, Inc. (VKTX) Soared on Tuesday (Insider Monkey)
Mar-04-25 04:05PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire) +9.30%
Mar-03-25 04:20PM	AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion. (Investor's Business Daily) -10.98%
Feb-28-25 05:45PM	Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
12:30PM	Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts? (Insider Monkey)
08:00AM	1 Biotech Stock to Buy in 2025, and 1 to Avoid (Motley Fool)
03:15AM	3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%. (Motley Fool)
Feb-26-25 11:38AM	Viking Therapeutics, Inc. (VKTX): A Bull Case Theory (Insider Monkey)
04:20AM	Is Viking Therapeutics a Buy Right Now? (Motley Fool)
Feb-24-25 01:01PM	Viking Therapeutics (VKTX): Among the Oversold Biotech Stocks to Buy Now (Insider Monkey) -14.29%
04:52AM	Wall Street Thinks This Weight Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk (Motley Fool)
Feb-22-25 12:45AM	Why Viking Therapeutics Inc. (VKTX) Surged On Friday? (Insider Monkey)
Feb-19-25 11:29PM	Why Viking Therapeutics, Inc. (VKTX) Went Up On Wednesday? (Insider Monkey) +10.36%
Feb-11-25 09:33AM	Why Viking Therapeutics Inc. (VKTX) Went Down on Monday (Insider Monkey)
Feb-10-25 07:13PM	Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today (Motley Fool) -7.34%
09:00AM	2 Stocks to Buy With Less Than $40 (Motley Fool)
04:20AM	3 No-Brainer Healthcare Stocks to Buy With $200 Right Now (Motley Fool)
Feb-08-25 04:27PM	The M&A boom of 2025 is just getting started and here are 5 potential targets (MarketWatch)
09:10AM	Viking Therapeutics price target lowered to $96 from $109 at B. Riley (TipRanks)
08:50AM	2 Stocks That Could Soar Again in 2025 (Motley Fool)
03:57AM	Down 65%, Is Viking Therapeutics Stock a Buy on the Dip? (Motley Fool)
Feb-07-25 05:30AM	The Drug Industry Is Having Its Own DeepSeek Moment (The Wall Street Journal)
Feb-06-25 04:02PM	Viking Therapeutics Plunged 6% On Its Earnings Report. Here's Why. (Investor's Business Daily) -6.09%
12:15PM	Viking Therapeutics Plummeted 7% On Its Earnings Report. Here's Why. (Investor's Business Daily)
11:51AM	Viking Therapeutics Reports Q4 2024 Financial Results, Advances VK2735 Trials (GuruFocus.com)
08:15AM	Has the Bubble Burst for Viking Therapeutics Stock? (Motley Fool)
07:40AM	Q4 2024 Viking Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
02:14AM	Viking Therapeutics Inc (VKTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising ... (GuruFocus.com)
Feb-05-25 04:55PM	Viking Therapeutics, Inc. (VKTX): One of Januarys Biggest Losers (Insider Monkey)
04:05PM	Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update (PR Newswire)

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FOEHR MATTHEW W	Director	Apr 11 '25	Option Exercise	8.00	20,786	166,288	132,036	Apr 14 07:26 PM
Rouan Sarah Kathryn	Director	Mar 31 '25	Buy	24.15	1,240	29,943	1,240	Apr 02 06:29 PM
Lian Brian	President & CEO	Jan 06 '25	Sale	42.75	194,490	8,313,601	2,366,570	Jan 06 08:16 PM
Mancini Marianna	Chief Operating Officer	Jan 06 '25	Sale	42.75	54,215	2,317,599	374,134	Jan 06 08:15 PM
ZANTE GREG	Chief Financial Officer	Jan 06 '25	Sale	42.75	50,309	2,150,595	165,259	Jan 06 08:14 PM
GREG ZANTE	Officer	Jan 06 '25	Proposed Sale	42.75	50,309	2,150,594		Jan 06 05:32 PM
MARIANNA MANCINI	Officer	Jan 06 '25	Proposed Sale	42.75	54,215	2,317,599		Jan 06 05:25 PM
BRIAN LIAN	Officer	Jan 06 '25	Proposed Sale	42.75	194,490	8,313,611		Jan 06 05:16 PM
MACARTNEY LAWSON	Director	Nov 08 '24	Option Exercise	5.80	2,000	11,600	49,965	Nov 08 06:22 PM
MACARTNEY LAWSON	Director	Nov 08 '24	Sale	68.67	2,000	137,333	47,965	Nov 08 06:22 PM
LAWSON MACARTNEY	Director	Nov 08 '24	Proposed Sale	68.67	2,000	137,333		Nov 08 06:13 PM
ZANTE GREG	Chief Financial Officer	Oct 28 '24	Option Exercise	7.49	94,001	704,282	281,053	Oct 28 09:48 PM
ZANTE GREG	Chief Financial Officer	Oct 28 '24	Sale	76.61	131,687	10,089,164	149,366	Oct 28 09:48 PM
GREG ZANTE	Officer	Oct 28 '24	Proposed Sale	78.03	131,687	10,275,537		Oct 28 04:37 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Option Exercise	4.88	11,000	53,680	11,000	Oct 25 07:28 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Sale	80.89	11,000	889,790	0	Oct 25 07:28 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Option Exercise	4.48	16,000	71,680	25,500	Oct 25 07:27 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Sale	79.50	16,000	1,272,000	9,500	Oct 25 07:27 PM
Rouan Sarah Kathryn	Director	Oct 25 '24	Proposed Sale	80.86	11,000	889,430		Oct 25 04:10 PM
SINGLETON J MATTHEW	Director	Oct 25 '24	Proposed Sale	79.47	16,000	1,271,479		Oct 25 04:01 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Option Exercise	1.19	10,300	12,257	19,800	Sep 20 09:21 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Sale	69.50	10,300	715,850	9,500	Sep 20 09:21 PM
Lian Brian	President & CEO	Sep 20 '24	Option Exercise	7.77	166,130	1,290,830	2,521,057	Sep 20 09:20 PM
Lian Brian	President & CEO	Sep 20 '24	Sale	70.83	216,130	15,308,553	2,304,927	Sep 20 09:20 PM
Lian Brian	Officer	Sep 20 '24	Proposed Sale	18.41	216,130	3,978,372		Sep 20 04:29 PM
SINGLETON J MATTHEW	Director	Sep 20 '24	Proposed Sale	69.50	10,300	715,850		Sep 20 04:13 PM
Lian Brian	President & CEO	Aug 21 '24	Option Exercise	7.77	1,000	7,770	2,355,927	Aug 22 07:23 PM
Lian Brian	President & CEO	Aug 21 '24	Sale	69.90	1,000	69,900	2,354,927	Aug 22 07:23 PM
SINGLETON J MATTHEW	Director	Aug 21 '24	Option Exercise	1.19	5,700	6,783	15,200	Aug 22 07:23 PM
SINGLETON J MATTHEW	Director	Aug 21 '24	Sale	69.72	5,700	397,430	9,500	Aug 22 07:23 PM
Lian Brian	Officer	Aug 21 '24	Proposed Sale	69.90	1,000	69,900		Aug 21 04:30 PM
SINGLETON J MATTHEW	Director	Aug 21 '24	Proposed Sale	69.72	5,700	397,404		Aug 21 04:18 PM
Lian Brian	President & CEO	Aug 19 '24	Option Exercise	7.77	112,870	877,000	2,467,797	Aug 19 08:13 PM
Lian Brian	President & CEO	Aug 19 '24	Sale	65.80	112,870	7,426,508	2,354,927	Aug 19 08:13 PM
SINGLETON J MATTHEW	Director	Aug 19 '24	Option Exercise	3.33	16,000	53,280	25,500	Aug 19 08:11 PM
SINGLETON J MATTHEW	Director	Aug 19 '24	Sale	62.22	16,000	995,453	9,500	Aug 19 08:11 PM
Lian Brian	Officer	Aug 19 '24	Proposed Sale	65.79	112,870	7,425,717		Aug 19 08:00 PM
SINGLETON J MATTHEW	Director	Aug 19 '24	Proposed Sale	62.21	16,000	995,360		Aug 19 07:47 PM
SINGLETON J MATTHEW	Director	Aug 14 '24	Option Exercise	8.00	20,786	166,288	30,286	Aug 14 08:03 PM
SINGLETON J MATTHEW	Director	Aug 14 '24	Sale	57.53	20,786	1,195,736	9,500	Aug 14 08:03 PM
SINGLETON J MATTHEW	Director	Aug 14 '24	Proposed Sale	57.53	20,786	1,195,735		Aug 14 04:38 PM
ZANTE GREG	Chief Financial Officer	Jul 30 '24	Sale	57.15	16,136	922,212	187,052	Jul 31 04:05 PM
Lian Brian	President & CEO	Jul 30 '24	Sale	57.58	115,859	6,670,604	2,354,927	Jul 31 04:05 PM
Mancini Marianna	Chief Operating Officer	Jul 30 '24	Sale	57.13	18,026	1,029,912	362,149	Jul 31 04:05 PM
GREG ZANTE	Officer	Jul 30 '24	Proposed Sale	57.15	16,136	922,232		Jul 30 05:58 PM
MARIANNA MANCINI	Officer	Jul 30 '24	Proposed Sale	57.13	18,026	1,029,888		Jul 30 05:56 PM
BRIAN LIAN	Officer	Jul 30 '24	Proposed Sale	57.58	115,859	6,671,057		Jul 30 05:55 PM
ZANTE GREG	Chief Financial Officer	May 03 '24	Option Exercise	4.86	34,249	166,285	241,610	May 03 08:51 PM
ZANTE GREG	Chief Financial Officer	May 03 '24	Sale	74.69	66,756	4,986,008	174,854	May 03 08:51 PM
Mancini Marianna	Chief Operating Officer	May 01 '24	Option Exercise	6.18	281,425	1,740,575	629,933	May 02 09:27 PM
Mancini Marianna	Chief Operating Officer	May 01 '24	Sale	78.66	281,425	22,136,474	348,508	May 02 09:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VKTX

Viking Therapeutics Inc

Upgrade your FINVIZ experience